Expertise related to medical marijuana issues:
• Social and economic impact
• Pros, cons, and ramifications of legalizing medical marijuana
• Costs of drug-prohibition laws and supply interdiction

Other related expertise:
• Health economics
• Pharmaceutical economics
• Health insurance reform
• Comparative effectiveness
• Cost/benefit analysis
• Economic assessment of medical technology and medical interventions
• Public policy issues relating to substance abuse
• Socioeconomic costs of drug and alcohol abuse - the harm users do to others

Additional Information:
• Quoted by Reuters about marijuana activists who are proposing that legalizing and taxing the drug could help California’s budget crisis; also quoted by CBS Radio’s San Francisco affiliate KCBS-AM, The Ventura Star, and The Daily Breeze about various health and health economics topics
• Founding editor-in-chief of Value in Health, the journal of the International Society for Pharmacoeconomics and Outcomes Research
• Author of Health Care in Hong Kong: An Economic Policy Assessment (1992)
• Author of numerous health-related op-ed pieces published in The Wall Street Journal, the San Francisco Chronicle, The San Diego Union-Tribune, Newsday and The Sacramento Bee
• Consultant to U.S. Health Care Financing Administration, U.S. Agency for Health Care and Policy Research, U.S. Centers for Disease Control, U.S. Public Health Service, U.S. Food and Drug Administration, U.S. Environmental Protection Agency, the Hungarian Parliament and the Rand Corp.

Joel W. Hay
Expert on issues related to the legalization of medical marijuana
Professor of Pharmaceutical Economics and Policy, USC School of Pharmacy